Report Detail
Global Plasma Protein Therapeutics Market Insights, Forecast to 2025
- RnM2652564 |
- 22 March, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Plasma Protein Therapeutics is widely used to treat Hemophilia, PID and Other. The most proportion of Plasma Protein Therapeutics is to treat PID, and the proportion is about 36.1% in 2017.
North America is the largest sales place, with a consumption value market share nearly 37% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 23.7% in 2017. China is an important market of Blood Product in Asia, accounting for 13.4% revenue market share of global market.
Baxter, CSL, Grifols are the leaders of the industry, with 71.6% market share in 2017, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
The global Plasma Protein Therapeutics market is valued at 21300 million US$ in 2018 and will reach 36100 million US$ by the end of 2025, growing at a CAGR of 6.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Plasma Protein Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Plasma Protein Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Plasma Protein Therapeutics in these regions.
This research report categorizes the global Plasma Protein Therapeutics market by top players/brands, region, type and end user. This report also studies the global Plasma Protein Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Market size by Product
Coagulation Factor
Immune Globulin
Albumin
Other
Market size by End User
Hemophilia
PID
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Plasma Protein Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Plasma Protein Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Plasma Protein Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Plasma Protein Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Plasma Protein Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Plasma Protein Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Plasma Protein Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Product
- 1.4.2 Coagulation Factor
- 1.4.3 Immune Globulin
- 1.4.4 Albumin
- 1.4.5 Other
- 1.5 Market by End User
- 1.5.1 Global Plasma Protein Therapeutics Market Size Growth Rate by End User
- 1.5.2 Hemophilia
- 1.5.3 PID
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Plasma Protein Therapeutics Market Size
- 2.1.1 Global Plasma Protein Therapeutics Revenue 2014-2025
- 2.1.2 Global Plasma Protein Therapeutics Sales 2014-2025
- 2.2 Plasma Protein Therapeutics Growth Rate by Regions
- 2.2.1 Global Plasma Protein Therapeutics Sales by Regions
- 2.2.2 Global Plasma Protein Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Plasma Protein Therapeutics Sales by Manufacturers
- 3.1.1 Plasma Protein Therapeutics Sales by Manufacturers
- 3.1.2 Plasma Protein Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Plasma Protein Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Plasma Protein Therapeutics Revenue by Manufacturers
- 3.2.1 Plasma Protein Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Plasma Protein Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Plasma Protein Therapeutics Price by Manufacturers
- 3.4 Plasma Protein Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Plasma Protein Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Plasma Protein Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Plasma Protein Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Plasma Protein Therapeutics Sales by Product
- 4.2 Global Plasma Protein Therapeutics Revenue by Product
- 4.3 Plasma Protein Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Plasma Protein Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Plasma Protein Therapeutics by Countries
- 6.1.1 North America Plasma Protein Therapeutics Sales by Countries
- 6.1.2 North America Plasma Protein Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Plasma Protein Therapeutics by Product
- 6.3 North America Plasma Protein Therapeutics by End User
7 Europe
- 7.1 Europe Plasma Protein Therapeutics by Countries
- 7.1.1 Europe Plasma Protein Therapeutics Sales by Countries
- 7.1.2 Europe Plasma Protein Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Plasma Protein Therapeutics by Product
- 7.3 Europe Plasma Protein Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Plasma Protein Therapeutics by Countries
- 8.1.1 Asia Pacific Plasma Protein Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Plasma Protein Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Plasma Protein Therapeutics by Product
- 8.3 Asia Pacific Plasma Protein Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Plasma Protein Therapeutics by Countries
- 9.1.1 Central & South America Plasma Protein Therapeutics Sales by Countries
- 9.1.2 Central & South America Plasma Protein Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Plasma Protein Therapeutics by Product
- 9.3 Central & South America Plasma Protein Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Plasma Protein Therapeutics by Countries
- 10.1.1 Middle East and Africa Plasma Protein Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Plasma Protein Therapeutics by Product
- 10.3 Middle East and Africa Plasma Protein Therapeutics by End User
11 Company Profiles
- 11.1 Shire (Baxalta)
- 11.1.1 Shire (Baxalta) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Shire (Baxalta) Plasma Protein Therapeutics Products Offered
- 11.1.5 Shire (Baxalta) Recent Development
- 11.2 CSL
- 11.2.1 CSL Company Details
- 11.2.2 Company Business Overview
- 11.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 CSL Plasma Protein Therapeutics Products Offered
- 11.2.5 CSL Recent Development
- 11.3 Grifols
- 11.3.1 Grifols Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Grifols Plasma Protein Therapeutics Products Offered
- 11.3.5 Grifols Recent Development
- 11.4 Octapharma
- 11.4.1 Octapharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Octapharma Plasma Protein Therapeutics Products Offered
- 11.4.5 Octapharma Recent Development
- 11.5 Kedrion
- 11.5.1 Kedrion Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Kedrion Plasma Protein Therapeutics Products Offered
- 11.5.5 Kedrion Recent Development
- 11.6 LFB Group
- 11.6.1 LFB Group Company Details
- 11.6.2 Company Business Overview
- 11.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 LFB Group Plasma Protein Therapeutics Products Offered
- 11.6.5 LFB Group Recent Development
- 11.7 Biotest
- 11.7.1 Biotest Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Biotest Plasma Protein Therapeutics Products Offered
- 11.7.5 Biotest Recent Development
- 11.8 BPL
- 11.8.1 BPL Company Details
- 11.8.2 Company Business Overview
- 11.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 BPL Plasma Protein Therapeutics Products Offered
- 11.8.5 BPL Recent Development
- 11.9 RAAS
- 11.9.1 RAAS Company Details
- 11.9.2 Company Business Overview
- 11.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 RAAS Plasma Protein Therapeutics Products Offered
- 11.9.5 RAAS Recent Development
- 11.10 CBPO
- 11.10.1 CBPO Company Details
- 11.10.2 Company Business Overview
- 11.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 CBPO Plasma Protein Therapeutics Products Offered
- 11.10.5 CBPO Recent Development
- 11.11 Hualan Bio
- 11.12 Kamada
12 Future Forecast
- 12.1 Plasma Protein Therapeutics Market Forecast by Regions
- 12.1.1 Global Plasma Protein Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Plasma Protein Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Plasma Protein Therapeutics Market Forecast by Product
- 12.2.1 Global Plasma Protein Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Plasma Protein Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Plasma Protein Therapeutics Market Forecast by End User
- 12.4 North America Plasma Protein Therapeutics Forecast
- 12.5 Europe Plasma Protein Therapeutics Forecast
- 12.6 Asia Pacific Plasma Protein Therapeutics Forecast
- 12.7 Central & South America Plasma Protein Therapeutics Forecast
- 12.8 Middle East and Africa Plasma Protein Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Plasma Protein Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Plasma Protein Therapeutics . Industry analysis & Market Report on Plasma Protein Therapeutics is a syndicated market report, published as Global Plasma Protein Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Plasma Protein Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
